Found: 10
Select item for more details and to access through your institution.
Effects of dalteparin on anti‐Xa activities cannot be predicted in critically ill COVID‐19 patients.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 6, p. 2982, doi. 10.1111/bcp.15208
- By:
- Publication type:
- Article
Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
- Published in:
- Bioscience Reports, 2021, v. 41, n. 7, p. 1, doi. 10.1042/BSR20210940
- By:
- Publication type:
- Article
Clinical sepsis phenotypes in critically ill COVID-19 patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02496-1
- By:
- Publication type:
- Article
Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: A prospective observational study from the Netherlands.
- Published in:
- Clinical Obesity, 2023, v. 13, n. 2, p. 1, doi. 10.1111/cob.12568
- By:
- Publication type:
- Article
Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The carbon footprint of a laparoscopic cholecystectomy.
- Published in:
- 2024
- By:
- Publication type:
- Letter